Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene Transfer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05523128
What this trial is testing

The Efficacy and Safety of ZS802 in Chinese Hemophilia A Patients.

Who this might be right for
Hemophilia A
Institute of Hematology & Blood Diseases Hospital, China 6
Very early researchNot Yet RecruitingNCT07685444
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations

Who this might be right for
Parkinson's Disease (PD)
Lingyi Biotech Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06980948
What this trial is testing

Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)

Who this might be right for
Chronic Neuropathic Pain
Sangamo Therapeutics 27
Early research (Phase 1)Active Not RecruitingNCT02337985
What this trial is testing

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Who this might be right for
AIDS-Related Burkitt LymphomaAIDS-Related Diffuse Large B-cell LymphomaAIDS-Related Plasmablastic Lymphoma+3 more
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT04684940
What this trial is testing

Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Who this might be right for
Hemophilia A With InhibitorHemophilia A With Anti Factor VIII
BioMarin Pharmaceutical 10
Early research (Phase 1)Ended earlyNCT02070406
What this trial is testing

Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center 4
Large-scale testing (Phase 3)Active Not RecruitingNCT05881408
What this trial is testing

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 148
Early research (Phase 1)WithdrawnNCT00429078
What this trial is testing

Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer

Who this might be right for
Gastric Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04186650
What this trial is testing

Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts

Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Institut National de la Santé Et de la Recherche Médicale, France 3
Large-scale testing (Phase 3)Study completedNCT03370913
What this trial is testing

Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 144
Not applicableLooking for participantsNCT05991336
What this trial is testing

Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy

Who this might be right for
Transfusion-dependent Beta-ThalassemiaGene Therapy
Institute of Hematology & Blood Diseases Hospital, China 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04281485
What this trial is testing

Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Pfizer 114
Testing effectiveness (Phase 2)Looking for participantsNCT03538899
What this trial is testing

Autologous Gene Therapy for Artemis-Deficient SCID

Who this might be right for
Severe Combined Immunodeficiency
University of California, San Francisco 24
Testing effectiveness (Phase 2)Study completedNCT01867333
What this trial is testing

Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 57
Not applicableNot Yet RecruitingNCT03727555
What this trial is testing

IT and IV Lentiviral Gene Therapy for X-ALD

Who this might be right for
X-linked Adrenoleukodystrophy
Shenzhen Geno-Immune Medical Institute 30
Early research (Phase 1)Ended earlyNCT00788307
What this trial is testing

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT00927134
What this trial is testing

Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children

Who this might be right for
Chronic Granulomatous Disease
University of Zurich 2
Not applicableActive Not RecruitingNCT06282432
What this trial is testing

Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)

Who this might be right for
Leukocyte Adhesion Deficiency
Rocket Pharmaceuticals Inc. 9
Early research (Phase 1)Study completedNCT01519349
What this trial is testing

Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis

Who this might be right for
Becker Muscular DystrophySporadic Inclusion Body Myositis
Nationwide Children's Hospital 15
Early research (Phase 1)Study completedNCT00004038
What this trial is testing

Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 20
Next Page